A Preliminary Study of fMRI-Guided rTMS in the Treatment of Generalized Anxiety Disorder: 6-Month Follow-Up
J Clin Psychiatry 2009;70(3):431-432 [letter]
© Copyright 2015 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Letter to the Editor
Sir: In our recent article, we investigated the effects
of functional magnetic resonance imaging (fMRI)-guided repetitive
transcranial magnetic stimulation (rTMS) treatment
for symptoms of generalized anxiety disorder (GAD). We found
that low-frequency rTMS treatment, administered with frameless
stereotaxy on the basis of individual functional imaging
data, significantly decreased anxiety symptoms associated with
GAD. However, when the article was published, the duration of
the rTMS effects beyond the 3-week treatment period was not
known. The possibility of long-lasting treatment effects, as has
been observed with short-term electroconvulsive therapy,
could have significant clinical and economic implications for
further utilization of rTMS for anxiety.